|
Tuesday, November 17, 2015
Print Current Day:
 |
|
| SESSION 1 SCHEDULE | |
|
Tuesday
SESSION 1:
PROGRESS IN TRANSCATHETER HEART VALVES AND NEW APPROACHES TO ASCENDING AORTIC DISEASE
Moderators:Lars G. Svensson, MD, PhD / Nicholas J.W. Cheshire, MD
|
|
| x | |
| 6:45 AM - 6:49 AM | Opening Remarks |
| Presenter(s):Frank J. Veith, MD | |
| View Slides in PDF | |
| 6:50 AM - 6:55 AM | Valve-In-Valve Transcatheter Aortic Valve Implantation (TAVI) And Mitral Valve-In-Valve Endovascular Repair: How Well Do They Work |
| Presenter(s):Dietmar H. Koschyk, MD | |
| View Slides in PDF | |
| 6:56 AM - 7:01 AM | Current Status Of Transcatheter Mitral Valve Repair: New Technology And Techniques |
| Presenter(s):Ted Feldman, MD | |
| View Slides in PDF | |
| 7:02 AM - 7:07 AM | Current Status And Future Prospects For TAVI: A Cardiac Surgeon’s Perspective |
| Presenter(s):Allan Stewart, MD | |
| View Slides in PDF | |
| 7:08 AM - 7:13 AM | Current Status And Future Prospects For TAVI: An Interventional Cardiologist’s Perspective |
| Presenter(s):Ted Feldman, MD | |
| View Slides in PDF | |
| ASCENDING AORTIC ENDOGRAFTING | |
| 7:14 AM - 7:19 AM | Ascending Aortic Endografting: Where Are We And What Are The Issues |
| Presenter(s):Ralf R. Kolvenbach, MD | |
| View Slides in PDF | |
| 7:20 AM - 7:25 AM | Endograft Repair Of Ascending Aortic Lesions And Type A Dissections With A Physician Sponsored IDE (PSIDE) For A Modified Valiant Device: Lessons Learned And What Are The Prospects For An Endograft-Valve Combined Device |
| Presenter(s):Carlos E. Donayre, MD / Rodney A. White, MD | |
| View Slides in PDF | |
| 7:26 AM - 7:31 AM | Ascending Aortic Endografting: Lessons Learned, Present Status And Future Potential: From A PSIDE Experience |
| Presenter(s):Rodney A. White, MD / Ali Khoynezhad, MD, PhD | |
| View Slides in PDF | |
| 7:32 AM - 7:37 AM | Access Routes And Off-The-Shelf Devices For Ascending Aortic Endovascular Repair |
| Presenter(s):Grayson H. Wheatley, MD | |
| View Slides in PDF | |
| 7:38 AM - 7:43 AM | Panel Discussion |
| END OF SESSION 1 | |
| SESSION 2 SCHEDULE | |
|
Tuesday
SESSION 2:
NEW DEVELOPMENTS IN TREATMENT OF AORTIC ARCH LESIONS AND DISSECTIONS
Moderators:Hazim J. Safi, MD / Timothy A.M. Chuter, DM
|
|
| x | |
| 7:44 AM - 7:49 AM | Aortic Arch Hybrid Repair With Supra-Aortic Trunks Re-routing: Current Indications, Long-Term Results And Complication Management In Patients With Degenerative Aneurysms And Dissections |
| Presenter(s):Yamume Tshomba, MD / Roberto Chiesa, MD / Germano Melissano, MD | |
| View Slides in PDF | |
| 7:50 AM - 7:55 AM | Current Management Of Aortic Arch Lesions With Hybrid Procedures: What Are Key Details And Precautions |
| Presenter(s):Eric E. Roselli, MD | |
| View Slides in PDF | |
| 7:56 AM - 8:01 AM | Redo Procedures For Aortic Arch Lesions: When Open; When Endo |
| Presenter(s):Michael J. Jacobs, MD | |
| View Slides in PDF | |
| 8:02 AM - 8:07 AM | Update On Endovascular Repair Of Arch Aneurysms Using The Internally Branched Endograft (Cook): Advantages, Limitations And 3-Center Midterm Results |
| Presenter(s):Stephan Haulon, MD | |
| View Slides in PDF | |
| 8:08 AM - 8:13 AM | What Are The Best Endovascular Techniques For Managing Arch Lesions – Including Branched Endografts And In Situ Fenestration |
| Presenter(s):Timothy A. Resch, MD, PhD / Bjőrn Sonesson, MD, PhD / Martin Malina, MD, PhD | |
| View Slides in PDF | |
| 8:14 AM - 8:19 AM | Status Of Sandwich (Parallel) Grafts For Total Endovascular Arch Replacement |
| Presenter(s):Armando C. Lobato, MD, PhD | |
| View Slides in PDF | |
| 8:20 AM - 8:25 AM | Parallel Grafts (Chimney And Periscope Grafts) For Arch Lesions: Advantages And Limitations |
| Presenter(s):Ralf R. Kolvenbach, MD | |
| View Slides in PDF | |
| 8:26 AM - 8:31 AM | What Is The Future For Endovascular Repair Of Aortic Arch Lesions: Advantages And Limitations Of Two Different Techniques Of Endograft Repair |
| Presenter(s):Tilo Kölbel, MD, PhD | |
| View Slides in PDF | |
| 8:32 AM - 8:37 AM | Update On Advantages Of Custom-Made Precurved Fenestrated Endograft (Naguta) For Arch Lesions: Durable Long-Term Results Are Better Than With Other Endo Techniques |
| Presenter(s):Yoshihiko Yokoi, MD | |
| View Slides in PDF | |
| 8:38 AM - 8:43 AM | Value And 3-Year Results With Branched Endograft From Bolton For Treating Complex Arch Lesions |
| Presenter(s):Toru Kuratani, MD, PhD | |
| View Slides in PDF | |
| 8:44 AM - 8:49 AM | Branched Endograft vs. Chimney Techniques For Treating Complex Arch Lesions: Which Is Best: When And Why |
| Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
| View Slides in PDF | |
| 8:50 AM - 8:58 AM | Panel Discussion |
| END OF SESSION 2 | |
| SESSION 3 SCHEDULE | |
|
Tuesday
SESSION 3:
TYPE B AORTIC DISSECTIONS (TBADs) AND THEIR TREATMENT: THORACIC AORTIC
Moderators:Christoph A. Nienaber, MD, PhD / Joseph S. Coselli, MD
|
|
| x | |
| 8:58 AM - 9:03 AM | What Do We Know About Intensive Medical Treatment For Acute TBADs: How Well Does It Work |
| Presenter(s):Frank A. Lederle, MD | |
| View Slides in PDF | |
| 9:04 AM - 9:09 AM | Natural History Of TBAD Patients Treated Medically: Predictors Of Deterioration And Which TBAD Patients Benefit Most From TEVAR (Based On 5-Year Results) |
| Presenter(s):Mark Conrad, MD, MMSc | |
| View Slides in PDF | |
| 9:10 AM - 9:15 AM | 4D Magnetic Resonance Imaging (MRI) In TBADs: Will It Enable Prediction Of Behavior (Aneurysm Formation, Etc.), Individualization Of Treatment And Assessment Of Its Effectiveness |
| Presenter(s):Rachel E. Clough, MD, PhD | |
| View Slides in PDF | |
| 9:16 AM - 9:21 AM | With Uncomplicated Acute TBAD Patients, What Factors Point To Deterioration On Medical Treatment And The Need For TEVAR: When Should TEVAR Be Performed: Based On New Data From The IRAD Registry |
| Presenter(s):Santi Trimarchi, MD, PhD / Christoph A. Nienaber, MD, PhD | |
| View Slides in PDF | |
| 9:22 AM - 9:27 AM | Optimal Management Of Malperfusion Syndrome From TBADs: What To Do When TEVAR Is Not Enough |
| Presenter(s):Weiguo Fu, MD | |
| View Slides in PDF | |
| 9:28 AM - 9:33 AM | Early Predictors Of Late Complications Including Aneurysm Formation In Patients With Acute TBADs |
| Presenter(s):Jean-Marc Alsac, MD, PhD | |
| View Slides in PDF | |
| 9:34 AM - 9:39 AM | Management Of Complications Of TBADs Before And After TEVAR: Intestinal, Spinal Cord And/Or Limb Ischemia |
| Presenter(s):Xin Li, MD / Chang Shu, MD | |
| View Slides in PDF | |
| 9:40 AM - 9:45 AM | False Lumen Occlusion Techniques With TBADs: When Are They Needed, How Are They Done, What Are The Complications: What Is The World Experience |
| Presenter(s):Tilo Kölbel, MD, PhD | |
| View Slides in PDF | |
| 9:46 AM - 9:51 AM | Strategies And Devices For Eliminating False Lumen Flows With TBADs And When Are They Needed |
| Presenter(s):Eric E. Roselli, MD | |
| View Slides in PDF | |
| 9:52 AM - 9:58 AM | Panel Discussion |
| 9:58 AM - 10:10 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 3 | |
| SESSION 4 SCHEDULE | |
|
Tuesday
SESSION 4:
MORE NEW DEVELOPMENTS IN TEVAR, THE AORTA AND MANAGING TBAD PATIENTS
|
|
| x | |
| 10:10 AM - 10:15 AM | Status Of Brain Embolic Protection Devices For TEVAR And TAVI: How Effective Are The Embrella, Sentinel And Triguard Neuroprotection Devices |
| Presenter(s):Jeffrey P. Carpenter, MD | |
| View Slides in PDF | |
| 10:16 AM - 10:21 AM | Effect Of TEVAR Timing On Freedom From Aortic Events And The Need For Reinterventions In TBADs: TEVAR Before 6 Months Is Better |
| Presenter(s):Toru Kuratani, MD, PhD | |
| View Slides in PDF | |
| 10:22 AM - 10:27 AM | A New Classification System For Aortic Dissections: DISSECT - Duration, Intimal Tear, Size Of Aorta, Segmental Extent, Complications, Thrombosis In False Lumen |
| Presenter(s):Michael D. Dake, MD / Christoph A. Nienaber, MD, PhD | |
| View Slides in PDF | |
| 10:28 AM - 10:33 AM | Correlation Between False Lumen Remodeling And Patent Intercostal Arteries |
| Presenter(s):Wei Guo, MD | |
| View Slides in PDF | |
| 10:34 AM - 10:39 AM | How The Petticoat Technique (Proximal Covered Stent And Distal Bare Stent) Is Better Than Standard TEVAR For TBAD Patients: Update On The STABLE I And II Trials |
| Presenter(s):Joseph V. Lombardi, MD | |
| View Slides in PDF | |
| 10:40 AM - 10:45 AM | Long-Term Results Of Medical Treatment And TEVAR For TBAD: False Lumen Thrombosis Is Not The End Of The Story: Thus The Need For Long-Term Surveillance And Late Reinterventions |
| Presenter(s):Götz M. Richter, MD, PhD | |
| View Slides in PDF | |
| 10:46 AM - 10:53 AM | Panel Discussion |
| Moderator(s): Michael D. Dake, MD / Frank J. Veith, MD | |
| 10:53 AM - 10:58 AM | What Defines Chronic TBAD: When And How Should It Be Treated Conservatively; By Endo Repair; By Open Repair |
| Presenter(s):Joseph E. Bavaria, MD | |
| View Slides in PDF | |
| 10:59 AM - 11:04 AM | Fenestrated And Branched EVAR (F/B EVAR) Is The Best Treatment For Thoracoabdominal Aneurysms (TAAAs) After TBADs – Especially Chronic TBADs: Advantages And Limitations |
| Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
| View Slides in PDF | |
| 11:05 AM - 11:10 AM | Current Optimal Treatment Of Patients With Chronic TBADs And Associated Complications And Aneurysms From Them |
| Presenter(s):Gustavo S. Oderich, MD, FACS | |
| View Slides in PDF | |
| 11:11 AM - 11:16 AM | Comparison Of Endovascular And Open Repair Of Degenerative And Dissecting Thoracic Aneurysmal Lesions In Patients Who Are Candidates For Both Types Of Repairs |
| Presenter(s):Yamume Tshomba, MD / Germano Melissano, MD / Roberto Chiesa, MD | |
| View Slides in PDF | |
| 11:17 AM - 11:22 AM | Secondary Interventions After TEVAR: Indications, Techniques And Results |
| Presenter(s):Mark K. Eskandari, MD | |
| View Slides in PDF | |
| 11:23 AM - 11:28 AM | Size (Diameter) And Normal Growth Rates Of The Aorta From Top To Bottom: At What Thoracic Aortic Size Is There A Real Risk Of Rupture |
| Presenter(s):John A. Elefteriades, MD | |
| View Slides in PDF | |
| 11:29 AM - 11:34 AM | The Mechanics Of TEVAR Device Conformability To Aortic And Arch Anatomy: How Do The Various Devices Compare |
| Presenter(s):Ludovic Canaud, MD, PhD | |
| View Slides in PDF | |
| 11:35 AM - 11:40 AM | True Lumen Volume/False Lumen Volume Ratio (<.8) On CT Can Predict The Need For TEVAR In Uncomplicated Acute TBAD |
| Presenter(s):Jean M. Panneton, MD | |
| View Slides in PDF | |
| 11:41 AM - 11:46 AM | Long-Term Results After TEVAR Are Not So Great: Some Notes Of Caution |
| Presenter(s):Dittmar Boeckler, MD | |
| View Slides in PDF | |
| 11:47 AM - 11:52 AM | Antegrade Delivery Of A Stent-Graft Into The Descending Aorta During Open Repair Of A Type A Aortic Dissection With Arch Involvement: A “Frozen Elephant Trunk”: How To Do It |
| Presenter(s):Joseph S. Coselli, MD / Ourania Preventza, MD | |
| View Slides in PDF | |
| 11:52 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 4 | |
| SESSION 5 SCHEDULE | |
|
Tuesday
SESSION 5:
NEW KEY DEVELOPMENTS IN THE MANAGEMENT OF PATIENTS WITH CAROTID DISEASE
Moderators:Frank J. Veith, MD / Wesley S. Moore, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | Update On The ACT I Trial Comparing CAS And CEA In Patients With High-Grade Asymptomatic Carotid Stenosis (ACS) |
| Presenter(s):Jon S. Matsumura, MD | |
| 1:06 PM - 1:11 PM | |
| Presenter(s):William A. Gray, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | DEBATE: Not So: Lessons Learned From US Datasets On Outcomes After CEA And CAS Show CAS Results Are Substantially Worse Than In CREST: The Brighter The Light The Darker The Shadow |
| Presenter(s):Ross Naylor, MD, FRCS | |
| View Slides in PDF | |
| TWO-WAY DEBATE | |
| 1:18 PM - 1:23 PM | DEBATE: Late Results Of ICSS Trial Show CAS And CEA To Be Equivalent In Patients With Symptomatic Carotid Stenosis |
| Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS / Martin M. Brown, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | DEBATE: Late Results Of ICSS Do Not Show Equivalence Of CAS And CEA: CEA Still Wins For Symptomatic Carotid Stenosis |
| Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Stroke And Death Rates (Early And Late) After CAS Are Higher Than The Randomized Controlled Trials (RCTs) Would Indicate: Therefore, We Should Be Less Aggressive With Our Use Of CAS – Especially In The Elderly And Asymptomatic Patients |
| Presenter(s):J. David Spence, MD | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | Asymptomatic Carotid Stenosis (ACS) Up To 80% Is Benign: What About Those Stenoses Over 85% - Especially When Associated With A Contralateral Occlusion: Which ACS Patients Should Be Treated Invasively And How |
| Presenter(s):Russell H. Samson, MD, RVT, FACS | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | Long-Term Results Of The SAMMPRIS (Intracranial Stenting) Trial In Patients With Intracranial Stenoses: What Does It Tell Us About Best Medical Treatment (BMRx); Compliance And Long-Term Benefits: The Recent VISSIT Trial Confirms The Negative Effects Of Intracranial Stenting |
| Presenter(s):Colin P. Derdeyn, MD | |
| View Slides in PDF | |
| 1:48 PM - 1:54 PM | Panel Discussion |
| Moderator(s): Wesley S. Moore, MD / Thomas S. Riles, MD | |
| 1:55 PM - 2:00 PM | Why Transcranial Doppler (TCD) Is Essential Before, During And After CAS, CEA And TAVI |
| Presenter(s):Zsolt Garami, MD | |
| 2:01 PM - 2:06 PM | Status Of Endovascular Treatment Of Total Carotid Occlusions: Advantages, Technique, Complications And How To Avoid Them |
| Presenter(s):Paul H.L. Kao, MD | |
| View Slides in PDF | |
| 2:07 PM - 2:12 PM | Diaphragm Of The Internal Carotid Artery: An Underdiagnosed Cause Of Stroke |
| Presenter(s):Emmanuel M. Houdart, MD | |
| View Slides in PDF | |
| 2:13 PM - 2:18 PM | DEBATE: Carotid Plaque Morphology Is Only Important In Symptomatic Patients |
| Presenter(s):Henrik Sillesen, MD, DMSc | |
| View Slides in PDF | |
| 2:19 PM - 2:24 PM | DEBATE: Not So: Carotid Plaque Morphology Is Helpful (With Other Criteria) In Predicting Stroke Risk In ACS Patients: What Percent Of ACS Patients Are High Risk And Justifiably Need CEA Or CAS |
| Presenter(s):Andrew N. Nicolaides, MS, FRCS / Stavros Kakkos, MD, PhD | |
| View Slides in PDF | |
| 2:25 PM - 2:30 PM | Risk Stratification Of Patients With Carotid Stenosis: How To Quantify: An Aging Brain Is More Important Than Plaque Characteristics – And Even Symptom Status |
| Presenter(s):Thomas G. Brott, MD | |
| View Slides in PDF | |
| 2:31 PM - 2:36 PM | Importance Of Preoperative And Perioperative Statin Dosage In Patients With Carotid Stenosis: Can They Change And Shrink Plaque: How Often |
| Presenter(s):Andrew N. Nicolaides, MS, FRCS / Stavros Kakkos, MD, PhD | |
| View Slides in PDF | |
| 2:37 PM - 2:42 PM | What Is New In The Effects Of Carotid Disease And Carotid Treatments (CEA And CAS) On Cognitive Function: Are There Differences Between CEA And CAS |
| Presenter(s):Wei Zhou, MD | |
| View Slides in PDF | |
| 2:43 PM - 2:48 PM | Tips And Tricks For Obtaining Distal Exposure Of The Internal Carotid Artery – To The Skull Base: Your ENT Surgeon Colleagues Can Help |
| Presenter(s):Ross Naylor, MD, FRCS | |
| View Slides in PDF | |
| 2:49 PM - 2:55 PM | Panel Discussion |
| 2:55 PM - 3:05 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 5 | |
| SESSION 6 SCHEDULE | |
|
Tuesday
SESSION 6:
EXCITING PROGRESS IN THE TREATMENT OF ACUTE STROKES
Moderators:Sriram S. Iyer, MD, FACC / Horst Sievert, MD
|
|
| x | |
| 3:05 PM - 3:10 PM | Urgent CEA And CAS Are Safe And Without A Bleeding Risk After A Small-To-Moderate Sized Stroke Is Treated By Thrombolysis |
| Presenter(s):Hernan Bazan, MD, FACS | |
| View Slides in PDF | |
| 3:11 PM - 3:16 PM | Carotid Interventions (CEA/CAS) In Acute Stroke Patients: Which Procedure On Which Patient And When |
| Presenter(s):R. Clement Darling III, MD | |
| View Slides in PDF | |
| 3:17 PM - 3:22 PM | Emergency CEA For Stroke In Evolution: When Is It Indicated And How Should It Be Done |
| Presenter(s):Hans-Henning Eckstein, MD, PhD | |
| View Slides in PDF | |
| 3:23 PM - 3:28 PM | Recent Progress In Endovascular Intracranial Treatment Of Acute Ischemic Strokes: Dramatic Positive Results Of ESCAPE, SWIFT-PRIME, EXTEND – IA, REVASCAT And MR CLEAN Trials: Why Are These Trials Positive And When Should Patients Be Treated And When Not |
| Presenter(s):L. Nelson Hopkins, MD | |
| View Slides in PDF | |
| 3:29 PM - 3:34 PM | Results And Techniques Of The ADAPT-FAST Trial Of A Newer Better Thrombus Removal Method For Treating Acute Strokes |
| Presenter(s):Alejandro M. Spiotta, MD | |
| View Slides in PDF | |
| 3:35 PM - 3:40 PM | New Developments In The Treatment Of Acute Strokes: It Is A New Treatment Horizon: Tips, Tricks, And Precautions And The Importance Of Balloon Tipped Guide Catheters To Decrease Prograde Flow During Clot Removal |
| Presenter(s):Klaus D. Mathias, MD | |
| View Slides in PDF | |
| 3:41 PM - 3:46 PM | Critical Elements In Stroke Interventions And Who Should Be In The Game |
| Presenter(s):Colin P. Derdeyn, MD | |
| View Slides in PDF | |
| 3:47 PM - 3:52 PM | Comments On Acute Stroke Treatment From A Pioneer: Why Others Than Neurointerventionists Must Be Involved And How Can They Be Trained |
| Presenter(s):Horst Sievert, MD | |
| View Slides in PDF | |
| 3:53 PM - 3:59 PM | Panel Discussion |
| END OF SESSION 6 | |
| SESSION 7 SCHEDULE | |
|
Tuesday
SESSION 7:
MORE ABOUT TBADs, THORACIC ANEURYSMS AND TEVAR
Moderators:Matt M. Thompson, MD / Nicholas J.W. Cheshire, MD
|
|
| x | |
| 4:00 PM - 4:05 PM | DEBATE: Stent-Grafts And Endovascular Repair Are Usually A Poor Option For Treating Aneurysm Patients With Connective Tissue Disorders |
| Presenter(s):Michael J. Jacobs, MD | |
| View Slides in PDF | |
| 4:06 PM - 4:11 PM | DEBATE: Stent-Grafts And Endovascular Repair Can Be A Reasonable Option For Treating Aneurysm Patients With Connective Tissue Disorders And Ehlers-Danlos Syndrome |
| Presenter(s):Vicente Riambau, MD, PhD | |
| View Slides in PDF | |
| 4:12 PM - 4:17 PM | How To Fix Endoleaks From 2° Intimal Tears At The Celiac Axis And SMA After Remote TEVAR For TBADs |
| Presenter(s):Ronald M. Fairman, MD | |
| View Slides in PDF | |
| 4:18 PM - 4:23 PM | F/B EVAR To Treat Thoracoabdominal Dissections And Post Dissection TAAAs: Indications, Contraindications And Pitfalls |
| Presenter(s):Stephan Haulon, MD | |
| View Slides in PDF | |
| 4:24 PM - 4:29 PM | Saccular vs. Fusiform Configurations In Thoracic Aortic Aneurysms (TAAs): Does It Matter |
| Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
| View Slides in PDF | |
| 4:30 PM - 4:35 PM | DEBATE: For Arch And Thoracic Aortic Lesions That Are Embolizing, When Anticoagulation, When Bare Stent, When Endograft |
| Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
| View Slides in PDF | |
| 4:36 PM - 4:41 PM | DEBATE: For Aortic Lesions That Are Embolizing, Endograft Treatment Is Generally The Best And Most Durable Treatment |
| Presenter(s):Michel Makaroun, MD | |
| View Slides in PDF | |
| 4:42 PM - 4:48 PM | Panel Discussion |
| END OF SESSION 7 | |
| SESSION 8 SCHEDULE | |
|
Tuesday
SESSION 8:
HOW SHOULD MOST PATIENTS WITH UNCOMPLICATED ACUTE TBAD BE TREATED: CONTROVERSY EXISTS AND WILL CONTINUE: THE PROS AND CONS OF EARLY TEVAR
Moderators:Lars G. Svensson, MD, PhD / Santi Trimarchi, MD, PhD
|
|
| x | |
| FOR EARLY TEVAR | |
| 4:48 PM - 4:53 PM | Most Patients With Acute/Subacute Uncomplicated TBADs Should Undergo TEVAR: The INSTEAD-XL RCT Shows Better Long-Term Survival With TEVAR Than With Medical Treatment |
| Presenter(s):Christoph A. Nienaber, MD, PhD | |
| View Slides in PDF | |
| 4:54 PM - 4:59 PM | Most Patients With Acute Uncomplicated TBAD Should Receive TEVAR Treatment: I Have Said It Before – Now I Know It Is True And No More Trials Are Needed |
| Presenter(s):Rodney A. White, MD | |
| 5:00 PM - 5:05 PM | Most Patients With Uncomplicated Acute TBAD Should Be Treated By TEVAR: Some Immediately And Some After A 6-12 Week Delay: How Can They Be Selected For Each Based On Data From The MOTHER Registry |
| Presenter(s):Matt M. Thompson, MD | |
| View Slides in PDF | |
| 5:06 PM - 5:11 PM | With Uncomplicated Acute TBAD There Is A High Risk Group That Should Be Treated By TEVAR: How Can They Be Selected And When Should They Be Treated |
| Presenter(s):Michael D. Dake, MD | |
| View Slides in PDF | |
| 5:12 PM - 5:17 PM | Medical Treatment Is Adequate For Most Patients With Uncomplicated TBAD Based On Current Long-Term Results |
| Presenter(s):John A. Elefteriades, MD | |
| View Slides in PDF | |
| 5:18 PM - 5:23 PM | The ADSORB Trial Tells Us What We Need To Know About Treating Uncomplicated TBADs: We Don’t Need Further Trials |
| Presenter(s):Jan S. Brunkwall, MD, PhD | |
| View Slides in PDF | |
| 5:24 PM - 5:29 PM | We Still Need More Evidence Before We Treat Most Uncomplicated Acute/Subacute TBAD Patients With TEVAR |
| Presenter(s):Michel Makaroun, MD | |
| View Slides in PDF | |
| 5:30 PM - 5:35 PM | Why Wider Use Of TEVAR For Uncomplicated TBADs Right Now May Not Be So Good |
| Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
| View Slides in PDF | |
| 5:36 PM - 5:41 PM | The INTACT-AD RCT Comparing TEVAR With Medical Treatment Will Give The Final Answer About The Best Treatment For Uncomplicated Acute/Subacute TBAD Patients: We Need This International Trial And How Will It Be Structured |
| Presenter(s):Firas F. Mussa, MD / Christoph A. Nienaber, MD, PhD | |
| View Slides in PDF | |
| 5:42 PM - 5:50 PM | Panel Discussion End of Program A |
| END OF SESSION 8 | |
| SESSION 9 SCHEDULE | |
|
Tuesday
SESSION 9:
NEW DEVELOPMENTS IN AAAs AND EVAR
Moderators:Enrico Ascher, MD / Ali F. AbuRahma, MD
|
|
| x | |
| 6:40 AM - 6:44 AM | Opening Remarks |
| Presenter(s):Frank J. Veith, MD | |
| View Slides in PDF | |
| 6:45 AM - 6:50 AM | Can Anything Besides Smoking Cessation Slow AAA Enlargement |
| Presenter(s):Frank A. Lederle, MD | |
| View Slides in PDF | |
| 6:51 AM - 6:56 AM | Redefining Adverse Neck Morphology With Newer EVAR Devices Which Perform Better In Short, Angulated And Large Diameter Necks And Those With A Thrombus Burden: What Are The Limits: From The ENGAGE Registry |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| 6:57 AM - 7:02 AM | Parallel Grafts To Revascularize Critical IMAs And Ectopic Renal Arteries When They Must Be Preserved: How To Do It |
| Presenter(s):Konstantinos P. Donas, MD | |
| View Slides in PDF | |
| 7:03 AM - 7:08 AM | How Will The Decreased Frequency And Increased Complexity Of Open AAA Repair Affect Vascular Surgery Training: What Can Be Done About It |
| Presenter(s):Jeffrey E. Indes, MD | |
| View Slides in PDF | |
| 7:09 AM - 7:14 AM | World’s Largest AAA Repair: All Large AAAs Do Not Rupture |
| Presenter(s):Dainis K. Krievins, MD / Christopher K. Zarins, MD | |
| View Slides in PDF | |
| 7:15 AM - 7:20 AM | EVAR For All AAA Patients: We Are Going Too Far: Some Large Aneurysms Should Not Be Fixed: Some Should Be Fixed By Open Repair |
| Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
| View Slides in PDF | |
| 7:21 AM - 7:26 AM | Outcomes Of EVAR For Inflammatory AAAs Are Favorable |
| Presenter(s):Furuzan Numan, MD | |
| View Slides in PDF | |
| 7:27 AM - 7:32 AM | Toward 15-Year Results Of The EVAR Trials And Individual Patient Data (IPD) Meta-Analysis With The DREAM, ACE And OVER Trials |
| Presenter(s):Roger M. Greenhalgh, MD | |
| View Slides in PDF | |
| 7:33 AM - 7:38 AM | Long-Term Results Of EVAR Are Better Than We Thought – Particularly With The Newer EVAR Devices |
| Presenter(s):Timur P. Sarac, MD | |
| View Slides in PDF | |
| 7:39 AM - 7:46 AM | Panel Discussion |
| END OF SESSION 9 | |
| SESSION 10 SCHEDULE | |
|
Tuesday
SESSION 10:
NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC BRANCH LESIONS – ESPECIALLY OF THE AORTO-ILIAC SEGMENT - AND TRAUMATIC AORTIC INJURY
Moderators:Kenneth Ouriel, MD, MBA / Barry T. Katzen, MD
|
|
| x | |
| 7:46 AM - 7:51 AM | Iliac Artery Endofibrosis In Hardcore Cyclists: Is Endovascular Treatment Ever Effective If They Won’t Give Up Their Sport Or Is Surgery The Only Effective Treatment: What Should The Operative Treatment Be |
| Presenter(s):Kenneth J. Cherry, MD | |
| View Slides in PDF | |
| 7:52 AM - 7:57 AM | Retrograde Open Superior Mesenteric Artery Stenting For Acute Mesenteric Ischemia: Indications, Techniques And Results |
| Presenter(s):Richard J. Powell, MD | |
| View Slides in PDF | |
| 7:58 AM - 8:03 AM | Parallel Grafts For Hypogastric Artery Revascularization During EVAR: Techniques, Advantages And Disadvantages |
| Presenter(s):Ronald L. Dalman, MD | |
| View Slides in PDF | |
| 8:04 AM - 8:09 AM | What Factors Predict When Treatment Of Blunt Traumatic Aortic Injuries Can Safely Be Delayed |
| Presenter(s):Robert S. Crawford, MD / Donald G. Harris, MD | |
| View Slides in PDF | |
| 8:10 AM - 8:14 AM | Panel Discussion |
| TREATMENT OF AORTO-ILIAC OCCLUSIVE DISEASE | |
| Moderator(s): Barry T. Katzen, MD / Kenneth Ouriel, MD, MBA | |
| 8:14 AM - 8:19 AM | In Claudication Due To Aorto-Iliac Disease, Supervised Exercise Is As Effective As Stenting When Added To BMRx: What Can Make Exercise Work And Why It Is Good Treatment: The CLEVER RCT Results |
| Presenter(s):Alan T. Hirsch, MD | |
| View Slides in PDF | |
| 8:20 AM - 8:25 AM | With Juxtarenal Aorto-Iliac Occlusions Open Surgical Treatment Is Best And Safest: What Precautions May Be Needed |
| Presenter(s):Giustino Marcucci, MD | |
| View Slides in PDF | |
| 8:26 AM - 8:31 AM | Most Aorto-Iliac Occlusions Should Be Treated Endovascularly With Stents: But There Are Limits That Require Open Surgery |
| Presenter(s):George H. Meier III, MD | |
| View Slides in PDF | |
| 8:32 AM - 8:37 AM | All Aorto-Iliac Occlusions Can Be Treated Endovascularly By Stents – If Certain Precautions Are Taken To Prevent Renal And Visceral Embolization |
| Presenter(s):Sonia Ronchey, MD, PhD / Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 8:38 AM - 8:43 AM | Complex Juxtarenal Aorto-Iliac Occlusions Can Be Treated Safely And Effectively With Covered Stents (The CERAB Technique) – However Renal Chimney Endografts May Be Required: Technique For Doing Them Without Risking Renal Or Visceral Embolization |
| Presenter(s):Peter C.J. Goverde, MD / Michel M.P. Reijnen, MD, PhD | |
| View Slides in PDF | |
| 8:44 AM - 8:49 AM | The CERAB Technique Using Covered Stents Is Better Treatment For Complex Aorto-Iliac Occlusions Than Bare Stents: Based On Flow Characteristics In An In Vitro Model |
| Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD | |
| View Slides in PDF | |
| 8:50 AM - 8:55 AM | Value Of Fusion Imaging To Facilitate Treatment Of Complex Aorto-Iliac Occlusions |
| Presenter(s):Klaus M. Overbeck, MD, MPhil | |
| View Slides in PDF | |
| 8:56 AM - 9:01 AM | Treatment Of TASC C And D Aorto-Iliac Occlusions With A Bifurcated Unibody Endograft (AFX – Endologix) Rather Than Kissing Stents Or Stent-Grafts: Technique And Early Results |
| Presenter(s):Thomas S. Maldonado, MD / Michel M.P. Reijnen, MD, PhD | |
| View Slides in PDF | |
| 9:02 AM - 9:09 AM | Panel Discussion |
| END OF SESSION 10 | |
| SESSION 11 SCHEDULE | |
|
Tuesday
SESSION 11:
VASCULAR LAPAROSCOPY, SOME ROBOTICS AND OPEN SURGERY SKILLS
Moderators:Nicholas J.W. Cheshire, MD / Alan B. Lumsden, MD, FACS
|
|
| x | |
| 9:09 AM - 9:14 AM | The Da Vinci Robot Facilitates Laparoscopic Aorto-Femoral Bypass For Occlusive Disease: Will It Displace Endovascular Techniques |
| Presenter(s):Jean-Marc Alsac, MD, PhD / Salma El Batti, MD | |
| View Slides in PDF | |
| 9:15 AM - 9:20 AM | Status Of Retroperitoneoscopic Techniques In Vascular Surgery: They Have Value But Will They Catch On |
| Presenter(s):Bernard J. Segers, MD | |
| View Slides in PDF | |
| 9:21 AM - 9:26 AM | A Propensity Score Matched Comparison Of Laparoscopic And Open Repair Of AAAs In Poor Candidates For EVAR: Is Laparoscopic Repair Better And Worth Learning |
| Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
| View Slides in PDF | |
| 9:27 AM - 9:32 AM | DEBATE: Laparoscopy And Articulated Robots For Aortic Surgery Is A Failed Experiment |
| Presenter(s):Willem Wisselink, MD | |
| View Slides in PDF | |
| 9:33 AM - 9:38 AM | DEBATE: Laparoscopic Robotic Aortic Surgery Is Not Dead But Has A Bright Future: What Will It Be And What Is The Evidence |
| Presenter(s):Fabien Thaveau, MD, PhD | |
| View Slides in PDF | |
| 9:39 AM - 9:44 AM | Open AAA Repair Is Becoming A Lost Art: Why And What Can Be Done About It: Tips And Tricks For Learning It And For Doing It Well |
| Presenter(s):Edward Y. Woo, MD | |
| View Slides in PDF | |
| 9:45 AM - 9:51 AM | Panel Discussion |
| 9:51 AM - 10:05 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 11 | |
| SESSION 12 SCHEDULE | |
|
Tuesday
SESSION 12:
UPDATE ON OPTIMAL TREATMENT METHODS FOR JUXTARENAL AND PARARENAL AAAs: IT IS STILL CONTROVERSIAL AND OTHER NEW DEVELOPMENTS IN TAAA TREATMENT, TEVAR AND TBAD
Moderators:Giovanni Torsello, MD / Matthew J. Eagleton, MD
|
|
| x | |
| ADVOCACY FOR SEVERAL METHODS OF JUXTA AND PARARENAL AAA REPAIR | |
| 10:05 AM - 10:10 AM | Open Repair Is The Procedure Of Choice For Juxta- And Pararenal AAAs: By What Approach |
| Presenter(s):Michael S. Conte, MD | |
| View Slides in PDF | |
| 10:11 AM - 10:16 AM | Fenestrated And Branched Grafts With EVAR (F/B EVAR) Is The Best Approach For Juxta- And Pararenal AAAs |
| Presenter(s):Timothy A.M. Chuter, DM | |
| View Slides in PDF | |
| 10:17 AM - 10:22 AM | Endografts With Parallel Grafts (Chimneys Or Periscopes) To The Renovisceral Arteries Are The Best Treatment For Juxta- Or Pararenal AAAs: Tips And Tricks For Doing Them Right |
| Presenter(s):Zoran Rancic, MD, PhD / Mario L. Lachat, MD | |
| View Slides in PDF | |
| 10:23 AM - 10:28 AM | For Juxta- And Pararenal AAAs Sometimes Chimney EVAR Is Best And When; Sometimes Fenestrated EVAR (F/EVAR With Z-Fen Endograft) Is Best And When: The Two Techniques Are Complementary |
| Presenter(s):Jason T. Lee, MD | |
| View Slides in PDF | |
| 10:29 AM - 10:34 AM | Use Of Parallel Grafts With EVAR To Treat Juxta- And Pararenal AAAs: A Simple Safe Technique |
| Presenter(s):David J. Minion, MD | |
| View Slides in PDF | |
| 10:35 AM - 10:40 AM | For Juxta- And Pararenal AAAs And Failed Standard EVARs Chimney EVAR Is Effective Midterm: Technical Tips And Tricks For Performing With Endurant Aortic Endografts: From The PROTAGORAS Registry |
| Presenter(s):Konstantinos P. Donas, MD / Giovanni Torsello, MD | |
| View Slides in PDF | |
| 10:41 AM - 10:46 AM | Late Results Of Parallel Grafts (Chimneys) For Juxta- And Pararenal AAAs Can Be Good If Done Right: Self-Expanding vs. Balloon-Expanding Branch Stents: Which Is Best |
| Presenter(s):Ralf R. Kolvenbach, MD | |
| View Slides in PDF | |
| OTHER RELATED TOPICS | |
| 10:47 AM - 10:52 AM | New Concepts And Improvements In Fenestrated Aortic Endografts And Improvements In Imaging For F/BEVAR With Fusion And IVUS |
| Presenter(s):Mark A. Farber, MD | |
| View Slides in PDF | |
| 10:53 AM - 10:58 AM | Perils Of The Widespread Use Of FEVAR: All Results Are Not Good |
| Presenter(s):Christopher J. Abularrage, MD | |
| View Slides in PDF | |
| 10:59 AM - 11:04 AM | Tips For Decreasing The Learning Curve For Performing F/BEVAR |
| Presenter(s):Andres Schanzer, MD | |
| View Slides in PDF | |
| 11:05 AM - 11:10 AM | Value Of Ultrasound (Duplex) In Surveillance Of Renal Artery Branches After B/FEVAR For Juxta- And Pararenal AAAs |
| Presenter(s):Martin R. Back, MD | |
| View Slides in PDF | |
| 11:11 AM - 11:19 AM | Panel Discussion |
| TAAA TREATMENT, TEVAR AND TBAD RELATED TOPICS | |
| Moderator(s): Mark A. Farber, MD / James F. McKinsey, MD | |
| 11:20 AM - 11:25 AM | Novel Simplified Endograft Device With Off-The-Shelf Potential For Treatment Of TAAAs: The Gore TAMBE Device: How It Works And Early Clinical Results |
| Presenter(s):Pierre Galvagni Silveira, MD, PhD | |
| View Slides in PDF | |
| 11:26 AM - 11:31 AM | Avoiding Pitfalls In Sizing The Diameter Of Endografts For TEVAR: The Timing Of Gated CT Scans Matters |
| Presenter(s):Juan C. Parodi, MD | |
| View Slides in PDF | |
| 11:32 AM - 11:37 AM | Goals Of Treatment For Complicated And Uncomplicated TBAD: Value Of IVUS And Other Tips And Tricks For Getting Good Outcomes: From A Large Single Center Experience |
| Presenter(s):Ali Azizzadeh, MD / Hazim J. Safi, MD | |
| View Slides in PDF | |
| 11:38 AM - 11:43 AM | Value Of Chimney Grafts In Aortic Arch Repairs For Dissections And For Aneurysms: Pros And Cons |
| Presenter(s):Jan S. Brunkwall, MD, PhD | |
| View Slides in PDF | |
| 11:44 AM - 11:49 AM | Open And Endovascular Treatment Of Lusorian Artery (Ectopic Right SCA) And Associated Aneurysms (Kommerell’s Diverticulum) |
| Presenter(s):Michael J. Jacobs, MD | |
| View Slides in PDF | |
| 11:50 AM - 12:00 PM | Panel Discussion Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| 12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 12 | |
| SESSION 13 SCHEDULE | |
|
Tuesday
SESSION 13:
OUTPATIENT VASCULAR AND BUSINESS ISSUES
Moderators:Richard J. Powell, MD / Enrico Ascher, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | Midterm Results Of Endovascular Treatment Of Common Femoral Artery Occlusive Disease Performed In An Outpatient Setting: It Works And Why |
| Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | Advantages And Limitations Of Same Day Discharge For Patients Undergoing EVAR: When Is It Safely Possible And When Not |
| Presenter(s):Maciej L. Dryjski , MD, PhD / Linda Harris, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Office Based Lower Extremity Endovascular Treatment Is Safe, Effective And Cost-Saving: How To Prevent Operator Conflict Of Interest And Patient Abuse: The NY Times Is Not Always Right |
| Presenter(s):Miguel F. Montero-Baker, MD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | 4-French Infrainguinal Interventions In An Outpatient Setting Are Safer And Effective: What Equipment Is Needed |
| Presenter(s):Jos C. van den Berg, MD, PhD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | With Lower Extremity Revascularization Procedures Increased Cost Does Not Improve Outcomes: What Risk Factors Increase Costs And How Should This Influence Treatment |
| Presenter(s):Richard J. Powell, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Outpatient Vascular (Angio) Centers: Are They Leading To Unethical Vascular Practices And Harming Patients: What Can Be Done About It |
| Presenter(s):Stephen M. Bauer, MD | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | Importance Of An Office Based Practice To SVS Members And Vascular Surgeons: How Can The Conflict Of Interest (COI) Issue Be Dealt With Fairly |
| Presenter(s):Kim J. Hodgson, MD | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | Assuring Quality Care In An Office Based Setting: Tips And Tricks For Opening An Outpatient Vascular Center And Doing It Right To Avoid Unmonitored And Unnecessary Procedures – As Described In The NY Times |
| Presenter(s):Krishna Jain, MD | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Centers For Amputation Prevention Have Clinical And Financial Advantages And Fill A Need: How To Set One Up And What Is Needed |
| Presenter(s):Richard F. Neville, MD | |
| View Slides in PDF | |
| 1:54 PM - 2:00 PM | Panel Discussion |
| END OF SESSION 13 | |
| SESSION 14 SCHEDULE | |
|
Tuesday
SESSION 14:
NEW TECHNIQUES, CONCEPTS AND UPDATES
Moderators:Kim J. Hodgson, MD / Daniel G. Clair, MD
|
|
| x | |
| 2:00 PM - 2:05 PM | Can Spiral Intermittent Limb Compression Be An Effective Treatment For CLI And Heart Failure |
| Presenter(s):Magdiel Trinidad Vasquez, MD | |
| View Slides in PDF | |
| 2:06 PM - 2:11 PM | Role Of Increased Shear Stress In Leading To Thrombosis: Mechanism And Significance For Vascular Devices And Reconstructions |
| Presenter(s):David H. Deaton, MD, FACS | |
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | Telemedicine For Vascular Surgery: Is It Feasible: What Is Its Status And What Are Its Limitations And Risks |
| Presenter(s):Clifford M. Sales, MD, MBA, FACS / Jonathan Levison, MD | |
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | Impact Of Delay In Treatment On Outcomes For CLI: For AAAs |
| Presenter(s):Katariina M. Noronen, MD | |
| View Slides in PDF | |
| 2:24 PM - 2:29 PM | Pneumatic Compression And Other Tricks For Brachial Access Hemostasis After Large Sheath Insertion |
| Presenter(s):Rajiv Parakh, MBBS, MS, FRCS | |
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | Transradial Access For Renal, Visceral And Lower Extremity Interventions: Equipment Needed, Tips And Tricks |
| Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
| View Slides in PDF | |
| 2:36 PM - 2:41 PM | Horizon And Nexus Endografts: A New Concept For Branch Endografting In The Thoracic And Abdominal Aorta |
| Presenter(s):Mario L. Lachat, MD | |
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | OCT (Optical Coherence Tomography) To Improve Crossing Of CTOs And Treatment By OCT Directed Atherectomy: The Avinger Pantheris Device And Its Results And How They Correlate With Plaque Histology |
| Presenter(s):Patrick E. Muck, MD, FACS / John B. Simpson, MD, PhD | |
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | Status Of Left Atrial Appendage Occlusive Devices To Prevent Strokes: Who Should Get Them |
| Presenter(s):Aamir S. Shah, MD / Ali Khoynezhad, MD, PhD | |
| View Slides in PDF | |
| 2:54 PM - 2:59 PM | Arteries And Grafts On Fire: Value And Limitations Of 18F-FDG PET CT In Diagnosing Arteritis And Graft Infections |
| Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) | |
| View Slides in PDF | |
| 3:00 PM - 3:05 PM | Update On Gaining Arterial Access For EVAR And TEVAR With Challenging Aorto-Iliac Anatomy: Tips And Tricks For Conduits And Direct Aortic Or Common Iliac Sheath Placement |
| Presenter(s):Jeffrey P. Carpenter, MD | |
| View Slides in PDF | |
| 3:06 PM - 3:20 PM | Panel Discussion And Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 14 | |
| SESSION 15 SCHEDULE | |
|
Tuesday
SESSION 15:
RENAL AND VISCERAL ARTERY ISSUES
Moderators:Timur P. Sarac, MD / James C. Stanley, MD
|
|
| x | |
| RENAL ARTERY ISSUES | |
| 3:20 PM - 3:25 PM | Current Status Of Renal Artery Stenting In Children And Adults: When Is It The Treatment Of Choice And What Is Its Future |
| Presenter(s):Thomas A. Sos, MD | |
| View Slides in PDF | |
| 3:26 PM - 3:31 PM | IV DSA Is The Best Way To Assess Occlusive Disease Of The Aorta And Its Branches In Children: Embolization May Be Best Treatment For Segmental Renal Artery Stenosis Causing Hypertension |
| Presenter(s):Kyung Cho, MD | |
| View Slides in PDF | |
| 3:32 PM - 3:37 PM | Value Of DEBs To Treat Renal Artery Lesions, Recurrent Lesions And ISR |
| Presenter(s):Fabrizio Fanelli, MD, EBIR | |
| View Slides in PDF | |
| 3:38 PM - 3:43 PM | Open Renal Revascularization Can Salvage Failed Renal PTAs And Stents And Do So Durably: Tips And Tricks For These Operations |
| Presenter(s):Thomas C. Bower, MD | |
| View Slides in PDF | |
| 3:44 PM - 3:49 PM | Acute Renal Artery Occlusions: Causes; How To Treat And How Long After An Acute Occlusion Can Kidneys Be Salvaged With Good Function: Mechanism For Such Salvage After Long Delays |
| Presenter(s):Samy S. Nitecki, MD | |
| View Slides in PDF | |
| 3:50 PM - 3:55 PM | Renal Artery Aneurysms Rarely Rupture EVEN When >2 cm: How Fast Do They Grow: When And How Should They Be Fixed |
| Presenter(s):Peter F. Lawrence, MD | |
| View Slides in PDF | |
| VISCERAL ARTERY ISSUES | |
| 3:56 PM - 4:01 PM | 10-Year Natural History Study Of Splanchnic Aneurysms (Splenic, Hepatic, Gastroduodenal And Mesenteric): When Should They Be Fixed And How |
| Presenter(s):Mark Conrad, MD, MMSc | |
| View Slides in PDF | |
| 4:02 PM - 4:07 PM | Endovascular Approaches To Treatment Of Giant Visceral Aneurysms (Up To 10 cm) |
| Presenter(s):Michele Rossi, MD | |
| View Slides in PDF | |
| 4:08 PM - 4:13 PM | Best Current Treatment For Mesenteric Ischemia: When Endo, When Open, When Hybrid |
| Presenter(s):Timur P. Sarac, MD | |
| View Slides in PDF | |
| 4:14 PM - 4:19 PM | Median Arcuate Ligament Syndrome: How To Diagnose And When And How To Treat Open, Laparoscopic Or Endovascularly: Does Treatment Work And How Should The Celiac Axis Be Managed |
| Presenter(s):Alan M. Dietzek, MD, RPVI, FACS / Keith D. Calligaro, MD | |
| View Slides in PDF | |
| 4:30 PM - 4:26 PM | Panel Discussion |
| END OF SESSION 15 | |
| SESSION 16 SCHEDULE | |
|
Tuesday
SESSION 16:
TOPICS RELATED TO OPEN SURGERY AND THE TREATMENT OF AORTIC COARCTATIONS
Moderators:Richard P. Cambria, MD / Hans-Henning Eckstein, MD, PhD
|
|
| x | |
| OPEN SURGERY TOPICS | |
| 4:26 PM - 4:31 PM | New Improved Techniques For Open TAAA Repair: Better Organ Protection And Using Hybrid (Gore) Stent Graft For Faster Branch Revascularization |
| Presenter(s):Yamume Tshomba, MD / Roberto Chiesa, MD / Enrico M. Marone, MD | |
| View Slides in PDF | |
| 4:32 PM - 4:37 PM | An Important Role For Open Surgery Exists For AAAs In 2015 And It Will In The Future |
| Presenter(s):Arno von Ristow, MD | |
| View Slides in PDF | |
| 4:38 PM - 4:43 PM | Prevention Of Incisional Hernias After Open AAA Repairs Via A Midline Laparotomy Incision By Mesh Augmented Primary Closure (The PRIMAAT Trial): Technique And Material |
| Presenter(s):Isabelle van Herzeele, MD, PhD / Frederik Berrevoet, MD / Filip Muysoms, MD | |
| View Slides in PDF | |
| 4:44 PM - 4:49 PM | The Worst Patients For EVAR Are The Best For A Mini-Laparotomy Open Repair: How Is It Done |
| Presenter(s):Francesco Spinelli, MD | |
| View Slides in PDF | |
| 4:50 PM - 4:55 PM | Newer Innovations And Technical Tips And Tricks For Anterior Spine Exposure And Large Vessel Mobilization: What Vascular Surgeons Need To Know |
| Presenter(s):Bauer E. Sumpio, MD, PhD | |
| View Slides in PDF | |
| 4:56 PM - 5:01 PM | Open Retroperitoneal Exposure Of The Entire Abdominal Aorta And Its Branches Via A Left Retroperitoneal Approach (Video Presentation) |
| Presenter(s):William J. Quinones-Baldrich, MD | |
| View Slides in PDF | |
| 5:02 PM - 5:07 PM | Advantages And Disadvantages Of Hybrid Repair For Thoracoabdominal Aortic Aneurysms (TAAAs): Tips And Tricks For Doing It Right |
| Presenter(s):Sebastian E. Debus, MD, PhD | |
| View Slides in PDF | |
| 5:08 PM - 5:13 PM | Challenges And Results Of Open Repairs Of Residual TAAAs Distal To Prior TEVAR For TBADs |
| Presenter(s):Manju Kalra, MBBS | |
| View Slides in PDF | |
| 5:14 PM - 5:19 PM | Some CLI In Hemodialysis Patients Is Best Treated By Open Bypass Rather Than An Endovascular Procedure: Which Patients With What Anatomy |
| Presenter(s):Mark G. Davies, MD | |
| View Slides in PDF | |
| 5:20 PM - 5:26 PM | Panel Discussion |
| AORTIC COARCTATION TOPICS | |
| Moderator(s): Hazim J. Safi, MD / Elchanan Bruckheimer, MBBS | |
| 5:26 PM - 5:31 PM | DEBATE: For Adult Coarctations And Their Complications When Is Endo OK And When Is Open Surgery Needed: What Are The Best And Safest Procedures |
| Presenter(s):Joseph E. Bavaria, MD | |
| 5:32 PM - 5:37 PM | DEBATE: Adult Coarctations And Complications Of Previous Coarctation Repairs Are Best Treated Endovascularly But One Must Be Innovative |
| Presenter(s):Jan S. Brunkwall, MD, PhD | |
| View Slides in PDF | |
| 5:38 PM - 5:43 PM | 5-Year Results With Balloon-Expandable Stent-Grafts In The Treatment Of Adult Aortic Coarctations |
| Presenter(s):Elchanan Bruckheimer, MBBS | |
| View Slides in PDF | |
| 5:44 PM - 5:49 PM | TEVAR Treatment Of Patch Aneurysms And Other Complications Of Prior Open Repairs: Advantages, Limitations And Precautions |
| Presenter(s):Dittmar Boeckler, MD | |
| View Slides in PDF | |
| 5:50 PM - 5:55 PM | New Generation Stent-Grafts For Treating Complications Of Aortic Coarctation Repairs: The Landscape Is Changing |
| Presenter(s):Colin D. Bicknell, MD, FRCS | |
| View Slides in PDF | |
| 5:56 PM - 6:03 PM | Panel Discussion End of Program B |
| END OF SESSION 16 | |
| SESSION 17 SCHEDULE | |
|
Tuesday
SESSION 17:
MANAGEMENT OF PULMONARY EMBOLISM: THE MOMENTUM FOR EFFECTIVE TREATMENT IS REAL – PART 1
Moderators:Michael R. Jaff, DO
|
|
| x | |
| 7:00 AM - 7:05 AM | Introduction To The Symposium |
| Presenter(s):Frank J. Veith, MD | |
| View Slides in PDF | |
| 7:05 AM - 7:15 AM | Welcome And Introduction |
| Presenter(s):Michael R. Jaff, DO | |
| 7:15 AM - 7:25 AM | The Basics Of Pulmonary Embolism: What Is The Role Of The History, Exam, Biomarkers? |
| Presenter(s):Ido Weinberg, MD, MSc | |
| View Slides in PDF | |
| 7:25 AM - 7:35 AM | The Basics Of Echocardiography For PE: What Must The Vascular Specialist Know, And Is An Emergent Echo Necessary |
| Presenter(s):David M. Dudzinski, MD | |
| View Slides in PDF | |
| 7:35 AM - 7:50 AM | What Is State-Of-The-Art Medical Therapy For PE |
| Presenter(s):Geno J. Merli, MD, MACP, FHM, FSVM | |
| View Slides in PDF | |
| 7:50 AM - 8:00 AM | Intravenous Thrombolytic Therapy For PE: Does It Work Acutely |
| Presenter(s):Christopher Kabrhel, MD, MPH | |
| View Slides in PDF | |
| 8:00 AM - 8:10 AM | Catheter-Directed Thrombolysis For PE: What Are The Long-Term Outcomes |
| Presenter(s):Rabih A. Chaer, MD | |
| View Slides in PDF | |
| 8:10 AM - 8:25 AM | Percutaneous Pharmacomechanical Intervention For PE: Do We Really Know About The Hows And Whens |
| Presenter(s):Nils Kucher, MD | |
| View Slides in PDF | |
| 8:25 AM - 8:35 AM | Lysis For PE - What About The Nuts And Bolts: Heparin, PTT And Fibrinogen Monitoring, And How Do You Know When You Are Done |
| Presenter(s):Raghu Kolluri, MD | |
| View Slides in PDF | |
| 8:35 AM - 8:45 AM | Technical Tips For Pharmacomechanical Intervention For PE: How Do I Do It |
| Presenter(s):Jeffrey Y. Wang, MD | |
| View Slides in PDF | |
| Moderator(s): Michael R. Jaff, DO | |
| 8:45 AM - 9:15 AM | Case Presentations/Discussion/Questions And Answers |
| Panelist(s): Rabih A. Chaer, MD / Christopher Kabrhel, MD, MPH / Raghu Kolluri, MD / Nils Kucher, MD / Geno J. Merli, MD, MACP, FHM, FSVM / Jeffrey Y. Wang, MD / Ido Weinberg, MD, MSc | |
| View Slides in PDF | |
| 9:15 AM - 9:45 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 17 | |
| SESSION 18 SCHEDULE | |
|
Tuesday
SESSION 18:
MANAGEMENT OF PULMONARY EMBOLISM: THE MOMENTUM FOR EFFECTIVE TREATMENT IS REAL – PART 2
Moderators:Michael R. Jaff, DO
|
|
| x | |
| 9:45 AM - 9:55 AM | PE Without DVT: What Does It Mean And Does It Matter |
| Presenter(s):Anil P. Hingorani, MD | |
| View Slides in PDF | |
| 9:55 AM - 10:10 AM | Percutaneous Thrombolysis And Thromboaspiration: The Impact Of Combination Therapy |
| Presenter(s):Narendra N. Khanna, MD, DM, FRCP, FACC | |
| View Slides in PDF | |
| 10:10 AM - 10:20 AM | Vortex Strategy For Massive PE |
| Presenter(s):Christopher J. Kwolek, MD | |
| View Slides in PDF | |
| 10:20 AM - 10:30 AM | ECMO And Surgical Thromboembolectomy For Massive PE: When, How And Why |
| Presenter(s):Nicholas G. Smedira, MD | |
| View Slides in PDF | |
| 10:30 AM - 10:45 AM | What Is The Modern Algorithm For Management Of Massive And Submassive PE |
| Presenter(s):Nils Kucher, MD | |
| View Slides in PDF | |
| 10:45 AM - 11:00 AM | Vena Cava Filters In PE Treatment: Do We Need To Do This, And If So, When |
| Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
| View Slides in PDF | |
| 11:00 AM - 11:15 AM | And Now For Something Completely Different: Catheter-Directed Thrombolysis In The Pediatric Population |
| Presenter(s):Peter H. Lin, MD | |
| View Slides in PDF | |
| 11:15 AM - 11:30 AM | The Team Approach To PE Management: The Emergence Of National PERT Centers |
| Presenter(s):Kenneth Rosenfield, MD | |
| View Slides in PDF | |
| Moderator(s): Michael R. Jaff, DO | |
| 11:30 AM - 11:45 AM | Challenging Cases And “PERT” Decisions |
| Panelist(s): Anil P. Hingorani, MD / Nils Kucher, MD / Christopher J. Kwolek, MD / Peter H. Lin, MD / Robert A. Lookstein, MD, FSIR, FAHA / Kenneth Rosenfield, MD / Nicholas G. Smedira, MD | |
| View Slides in PDF | |
| 11:45 AM - 12:00 PM | Questions And Answers |
| 12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 18 | |
| SESSION 19 SCHEDULE | |
|
Tuesday
SESSION 19:
RAPID EXPANSION OF OPPORTUNITIES FOR EFFECTIVE TREATMENT OF LARGE VEIN STENOSIS, THROMBOSIS, AND OCCLUSION
Moderators:Kenneth Ouriel, MD, MBA / Peter Gloviczki, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | Lower Extremity Venous Occlusive Disease: A Rapidly Progressing Field With Major Opportunities For Improving Clinical Outcomes |
| Presenter(s):Peter Gloviczki, MD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | Large Vein Occlusive Disease: A Global Health Issue In 2015 And Beyond |
| Presenter(s):Manj S. Gohel, MD, RCS, FEBVS | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Quality Of Life Surveys In Patients Undergoing Intervention For Chronic Venous Disease: The Good, The Bad, And The Ugly |
| Presenter(s):Cees H.A. Wittens, MD, PhD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Non-Thrombotic May-Thurner Syndrome: Defining Pathology Mandating Treatment From Normal Anatomy |
| Presenter(s):Brian G. DeRubertis, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | When And How Should Pelvic Venous Compression Syndromes Be Treated |
| Presenter(s):David L. Gillespie, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Treating Iliofemoral DVT In Pregnancy: Anticoagulation Alone Is No Longer Acceptable In Most Patients |
| Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | Role Of Inflammation In DVT: Its Relationship With Thrombosis |
| Presenter(s):Thomas W. Wakefield, MD | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | Hemodynamics Of Venous Disease: Toward A Better Understanding And Consensus |
| Presenter(s):Byung-Boong Lee, MD | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Third Party Payment For Venous Interventions: Current Deliberations And Gazing Into The Crystal Ball |
| Presenter(s):Sean P. Roddy, MD | |
| View Slides in PDF | |
| 1:54 PM - 1:59 PM | Panel Discussion |
| END OF SESSION 19 | |
| SESSION 20 SCHEDULE | |
|
Tuesday
SESSION 20:
ENDOVASCULAR INTERVENTIONS AND PHARMACOLOGIC REGIMENS FOR ACUTE LOWER EXTREMITY DVT: NEW EVIDENCE FOR CLINICAL SAFETY AND EFFECTIVENESS
Moderators:Thomas W. Wakefield, MD / Mark J. Garcia, MD
|
|
| x | |
| 2:00 PM - 2:05 PM | ATTRACT Study Of rt-PA For Acute DVT: Almost 7 Years And Almost 700 Patients, Almost Done: What Will We Find |
| Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
| View Slides in PDF | |
| 2:06 PM - 2:11 PM | Acute DVT Should Be Managed With An Aggressive Interventional Approach: Large Experience From South Asia |
| Presenter(s):Narendra N. Khanna, MD, DM, FRCP, FACC | |
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | Thrombolysis For DVT: Predictors Of Success |
| Presenter(s):Rabih A. Chaer, MD | |
| View Slides in PDF | |
| 2:18 PM - 2:22 PM | BERNUTIFUL: A Beautifully Designed Trial To Evaluate Ultrasound-Assisted Thrombolysis For DVT |
| Presenter(s):Nils Kucher, MD / Iris Baumgartner, MD | |
| View Slides in PDF | |
| 2:23 PM - 2:28 PM | How Long To Anticoagulate After DVT: Duplex Imaging Guides Treatment Duration |
| Presenter(s):Timothy K. Liem, MD, MBA | |
| View Slides in PDF | |
| 2:29 PM - 2:34 PM | Understanding The Genetics Of Warfarin Dosing And Implications For Safer Anticoagulant Therapy |
| Presenter(s):Karthikeshwar Kasirajan, MD | |
| View Slides in PDF | |
| 2:35 PM - 2:40 PM | New Oral Anticoagulants For Extending Treatment Of DVT: Do They Alter The Risk/Benefit Ratio |
| Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
| View Slides in PDF | |
| 2:41 PM - 2:50 PM | Panel Discussion |
| 2:51 PM - 3:15 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 20 | |
| SESSION 21 SCHEDULE | |
|
Tuesday
SESSION 21:
NEW DEVICES FOR TREATING LARGE VEIN OCCLUSIVE DISEASE
|
|
| x | |
| 3:16 PM - 3:21 PM | The First Comparative Study Of Four Dedicated Stents For The Venous System |
| Presenter(s):Rick De Graaf, MD, PhD | |
| View Slides in PDF | |
| 3:22 PM - 3:27 PM | DEBATE: Marketed Stents Designed For Arteries Are More Than Adequate For Treating Venous Disease |
| Presenter(s):Mark J. Garcia, MD | |
| View Slides in PDF | |
| 3:28 PM - 3:33 PM | DEBATE: Arterial Stents Are Suboptimal In Veins: Newer Stents Designed For The Venous Side Are Mandatory |
| Presenter(s):Seshadri Raju, MD | |
| View Slides in PDF | |
| 3:34 PM - 3:39 PM | Cutting Balloon Angioplasty For Symptomatic Femoropopliteal Vein Stenoses |
| Presenter(s):Thomas O. McNamara, MD | |
| View Slides in PDF | |
| 3:40 PM - 3:45 PM | The Cook Zilver Vena Venous Stent: Update From The VIVO Trial |
| Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
| View Slides in PDF | |
| 3:46 PM - 3:51 PM | Early Experience With The Veniti VICI Venous Stent And Update On The VIRTUS Trial |
| Presenter(s):William A. Marston, MD | |
| View Slides in PDF | |
| 3:52 PM - 3:57 PM | Rapid Clearance Of Acute Thrombus From The Large Veins: The AngioVac System |
| Presenter(s):David J. Dexter, MD | |
| View Slides in PDF | |
| 3:58 PM - 4:03 PM | Ultrasound-Enhanced Thrombolysis For Older DVT: Update From The ACCESS Study |
| Presenter(s):Mark J. Garcia, MD | |
| View Slides in PDF | |
| 4:04 PM - 4:09 PM | Panel Discussion |
| END OF SESSION 21 | |
| SESSION 22 SCHEDULE | |
|
Tuesday
SESSION 22:
THE INFERIOR VENA CAVA: CHALLENGES AND OPPORTUNITIES
Moderators:Timur P. Sarac, MD / Seshadri Raju, MD
|
|
| x | |
| 4:10 PM - 4:15 PM | Surgical Reconstruction Of The Iliocaval Segment: When And How |
| Presenter(s):Peter Gloviczki, MD | |
| View Slides in PDF | |
| 4:16 PM - 4:21 PM | Recanalization Of The Inferior Vena Cava: Technique And Results |
| Presenter(s):Erin H. Murphy, MD / Seshadri Raju, MD | |
| View Slides in PDF | |
| 4:22 PM - 4:27 PM | Advantages Of Robotic Vena Cava Surgery Over Traditional Techniques |
| Presenter(s):Samuel R. Money, MD, MBA | |
| View Slides in PDF | |
| 4:28 PM - 4:33 PM | Acute And Chronic IVC Occlusion: Why It Occurs And Options For Treatment |
| Presenter(s):David L. Gillespie, MD | |
| View Slides in PDF | |
| 4:34 PM - 4:39 PM | Massive DVT And Pulmonary Embolism: Early Institution Of ECMO And Aggressive Anticoagulant Improves Survival |
| Presenter(s):Mark G. Davies, MD | |
| View Slides in PDF | |
| 4:40 PM - 4:45 PM | Embolic Risk Of Percutaneous Thrombectomy And Thrombolysis For DVT: An IVC Filter Is Not Necessary |
| Presenter(s):Peter H. Lin, MD | |
| View Slides in PDF | |
| 4:46 PM - 4:51 PM | Newer, Safer Retrievable IVC Filter Designs Alter Risks And Rewards And Will Expand Applicability Indications |
| Presenter(s):Richard G. McWilliams, FRCR, EBIR | |
| View Slides in PDF | |
| 4:52 PM - 5:00 PM | Panel Discussion End of Program C |
| END OF SESSION 22 | |